Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

SanBio reports positive results from Phase II SB623 trial

CT scan showing cerebral contusions, haemorrhage within the hemispheres, subdural hematoma, and skull fractures. Credit: Delldot.



  • Cerebral contusions, haemorrhage within the hemispheres, subdural hematoma, skull fractures

Go Top